Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / COM
-
Number of holders
-
154
-
Total 13F shares, excl. options
-
49,081,412
-
Shares change
-
-5,086,054
-
Total reported value, excl. options
-
$344,521,272
-
Value change
-
-$24,975,036
-
Put/Call ratio
-
122%
-
Number of buys
-
78
-
Number of sells
-
-69
-
Price
-
$7.02
Significant Holders of CLOVIS ONCOLOGY INC - COM (CLVSQ) as of Q1 2021
213 filings reported holding CLVSQ - CLOVIS ONCOLOGY INC - COM as of Q1 2021.
CLOVIS ONCOLOGY INC - COM (CLVSQ) has 154 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 49,081,412 shares
.
Largest 10 shareholders include STATE STREET CORP (9,892,877 shares), BlackRock Inc. (7,819,010 shares), VANGUARD GROUP INC (7,623,193 shares), Palo Alto Investors LP (4,484,411 shares), MILLENNIUM MANAGEMENT LLC (2,224,604 shares), GEODE CAPITAL MANAGEMENT, LLC (1,660,342 shares), MORGAN STANLEY (1,030,479 shares), NORTHERN TRUST CORP (974,926 shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (733,873 shares), and CITIGROUP INC (689,258 shares).
This table shows the top 154 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.